Skip to content
OpenCapital
Get started

MSCI MSCI Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By segment

See full
Index0.2%+100%

Other financials

Income statement

See full
Revenue$850.8M+14.1%
Gross profit$709.0M+16.4%
Operating income$456.9M+21.2%
Net income$406.0M+40.7%
EPS (diluted)$5.53+49.1%

Balance sheet

See full
Cash & equivalents$385.3M+6.8%
Total debt$6.6B+40.1%
Total equity-$2.8B-189%
Total assets$5.5B+3.8%

Cash flow

See full
Operating cash flow$306.8M+1.7%
CapEx$2.8M-75.9%
Free cash flow$304.0M+4.8%

Valuation

See full
Market cap$40.39B-9.3%
Enterprise value$46.58B-4.6%
P/E30.6×-7.2×
P/S12.5×-2.4×

Profitability

See full
Gross margin82.9%+0.7pp
Operating margin55.4%+1.8pp
Net margin40.7%+1.7pp
FCF margin48.3%-1.8pp

Returns & leverage

See full
Return on equity113.8%—
Debt / equity6.8×—
Current ratio0.9×0.0×